Exponent (EXPO) Q2 Revenue Rises 1%

Exponent (NASDAQ:EXPO), a consulting firm specializing in engineering and scientific problem-solving, delivered its second-quarter fiscal 2025 results on July 31, 2025. Exponent reported $142.0 million in total revenue (GAAP) for Q2 FY2025, a 1% increase from Q2 FY2024, narrowly exceeding its own expectations for flat to slightly lower growth. Diluted earnings per share (GAAP) was $0.52 in Q2 FY2025, down from $0.57 per diluted share (GAAP) in Q2 FY2024. While revenue edged up, profitability narrowed, with EBITDA (non-GAAP) and net income both declining year over year due to rising operating costs. Overall, the quarter demonstrated stable performance, mainly due to reactive, dispute-related engagements, but highlighted ongoing margin pressure and mixed demand trends across segments.Exponent operates as a technical consulting firm offering investigative and advisory services in areas such as engineering, data science, biomedical engineering, and environmental health, underpinning the company’s ability to take on highly specialized projects across complex industries.The company’s recent priorities have centered on broadening its client base, increasing technical specialization, and expanding service offerings into emerging areas like digital health and artificial intelligence usability. Key success factors include its exposure to diverse industries, premium pricing for specialized expertise, and continual investment in recruiting and retaining expert consultants.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool